A woman and man gesture with their hands while talking in a laboratory.
Gerard "Gerry" Blobe and Tammara Watts work to build the next generation of cancer scientists and physicians. Photo by Eamon Queeney/Duke University School of Medicine.

The Challenge of Becoming a Physician-Scientist

Published

Five years after joining the faculty at Duke University School of Medicine and Duke Cancer Institute, Tammara Watts, MD, PhD, associate professor of head and neck surgery & communication sciences, is finally outfitting her own lab.

In 2019, as a newly recruited surgeon and scientist, she was charged with finding an established researcher who would agree to lend her space to get her research program started. This model is not uncommon at Duke for junior physician-scientists. They are just beginning their clinical practices, and without large amounts of independent federal research funding, starting their own lab at the same time is a heavy lift.

Watts found a generous mentor and colleague in Gerard “Gerry” Blobe, MD, PhD, professor of medicine, cell biology, and pharmacology and cancer biology. “I didn’t know a single person on campus, but I called a lot of people. Gerry was gracious enough to take me in,” Watts said. “He gave me a quarter of his lab. That’s where my team works. He gave me use of his common equipment, so I didn’t have to spend any money on that. His team has helped me out in a pinch when my folks have not been able to come in for experiments, and vice versa.”

Watts would not be setting up her own lab without a $3.1 million grant that she received in April 2024. Awarded by the National Institutes of Health (NIH), it’s an R01 — an independent investigator grant that funds a specific, mature research project for up to five years.

She attributes this success to many factors, including the lab home with Blobe, mentoring and collaboration from other Duke colleagues, and a Duke Cancer Institute (DCI) pilot grant that allowed her to collect preliminary data that she used to show proof of concept in the NIH grant application.

Watts’s experiences demonstrate some of the challenges of building a career as a clinician-scientist. Paying for lab space is just one of the hurdles. Putting in the time required is another; It takes years beyond earning an MD-PhD to build a lab. Increasingly, new PhD graduates go into industry, said Blobe, who is also director of education and training at DCI. “The number of postdocs on campus has declined pretty significantly,” he said. That’s a problem because academic scientists, and particularly physician-scientists, who both care for patients and conduct research, drive discovery of new and better treatments.

To nurture the next generation of scientists and build a diverse, robust cancer workforce, the National Cancer Institute and DCI have put increased emphasis on education and training. DCI has launched 19 new training initiatives in the last five years, including efforts to engage high school students and undergraduates, all the way to junior faculty. (See “Filling in the Gaps.”)

Tammara Watts, MD, PhD / Associate Professor of Head and Neck Surgery & Communications Sciences

Many of the new training programs focus on groups that are typically under-represented in medicine. Duke is also increasingly focusing on reaching out to the Durham community to engage middle and high school students in science and get them interested in coming to Duke, in collaboration with DCI Associate Director of Community Outreach, Equity, and Engagement Tomi Akinyemiju, PhD, Blobe said.

Creating a clinical and academic workforce that reflects the population of the people it serves is a priority for Duke Cancer Institute, said Steven Patierno, PhD, deputy director of DCI, who has for more than 20 years directed programs to eliminate cancer health disparities and achieve health equity.

As Watts pointed out, several studies show that having a diverse physician workforce is linked to better patient outcomes, including a 2023 study from John Snyder, MD, of the US

Department of Health and Human Services, which showed that increased Black representation in the primary care physician workforce was associated with a higher life expectancy for Black patients and inversely associated with all cause Black mortality.

A man and a woman in front of a laboratory bench, smiling at the camera.
Gerard "Gerry" Blobe and Tammara Watts work to build the next generation of cancer scientists and physicians.

Disparate Survival, Disparate Workforce

In Watts’ new NIH-funded project, she and colleagues will use next-generation genomic sequencing and other advanced technologies to explore whether there are biological reasons that Black people with head and neck cancers do poorly, even after controlling for

HPV status and social determinants of health like income and access to care.

Her previous research has been in cancer biology, and she had never thought of studying health disparities. But her peers at Duke, including Nosayaba Osazuwa-Peters, PhD, a head and neck cancer epidemiologist, encouraged her to explore the questions that nagged at her as she treated patients. “He really got me thinking,” Watts said. “Everybody says, oh, you’ve got HPV-positive throat cancer, it’s a better prognosis. But I know my Black patients don’t do as well.” Some studies have shown that Black patients with HPV-positive throat cancer are more than three times as likely to die of the disease compared to white patients, Watts said.

Watts got started on initial explorations with a small grant from NRG Oncology and a research pilot grant directly from DCI. The preliminary data she generated helped her win the NIH grant. “We asked some questions like if we took pathology slides and used spatial transcriptomics, could we do an analysis of gene differences between two racial groups to see if there were some driver genes that may be of importance?”

Spatial transcriptomics uses high-resolution pathology images combined with RNA sequencing, so scientists can examine gene expression in the context of the exact position of the cells in tissue. Her initial study showed that the approach is feasible and can be scaled up.

The discoveries she and collaborators make will help all patients with HPV-positive throat cancer, Watts said. “Even aside from racial disparities, we don’t fully understand head and neck cancer,” said Kyle Lafata, PhD, a co-investigator on Watts’s new NIH grant and theThaddeus V. Samulski Associate Professor of Radiation Oncology. “For example, things like immunotherapy have really taken off and work for cancers such as breast and lung cancer,” he said. “But most of the trials have not worked well for head and neck cancer. So we really have to go back to the basic biology of those tumors.”

In addition to funding the science, the grant supports new efforts to help diversify the oncology workforce, including a surgery resident from Howard University who will spend two years at Duke conducting oncology research in an area of their choosing. This part of the grant will also support a high school student from the City of Medicine Academy in Durham to spend a summer in Watts’s lab or that of any of her co-investigators to earn school credit while learning what it’s like to conduct research.

The grant will also fund an effort to make laboratory space available to junior faculty who want to get started conducting translational research. “I’d like to have a dedicated incubator lab with all of the equipment that someone would need to run experiments, so that their precious pilot funds and startup funds can be used purely for generating data,” said Watts, who is associate director for equity, diversity, and inclusion at DCI.

None of these plans would have been possible if Watts hadn’t found a temporary home for her research with Blobe’s lab. “I credit a lot of my ability to write these grants and get the data and brainstorm ideas for Gerry taking me in,” Watts said. “I have benefited from outstanding mentorship throughout my career in academic medicine,” she said. “If we aim to improve workforce diversity, we must create welcoming environments for the development of early career faculty interested in pursuing research.”

This article was originally published in the Fall 2024 Breakthroughs. Read more about DCI's breakthrough research and patient care in this biannual magazine.